P1531: TIXAGEVIMAB‐CILGAVIMAB THERAPY IN THE PREVENTION OF SARS‐COV2 INFECTION IN NON‐HODGKIN‐B LYMPHOMAS AND HODGKIN LYMPHOMAS UNDER TREATMENT: OUR EXPERIENCE
Saved in:
Published in | HemaSphere Vol. 7; no. S3; pp. e81676fe - n/a |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Philadelphia, PA
Lippincott Williams & Wilkins
08.08.2023
Wiley |
Online Access | Get full text |
ISSN | 2572-9241 2572-9241 |
DOI | 10.1097/01.HS9.0000973000.81676.fe |
Cover
ISSN: | 2572-9241 2572-9241 |
---|---|
DOI: | 10.1097/01.HS9.0000973000.81676.fe |